Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel

Cardiovasc Res. 2008 Jun 1;78(3):458-65. doi: 10.1093/cvr/cvn052. Epub 2008 Feb 23.

Abstract

Aims: In cardiomyocytes, protein kinase D1 (PKD1) plays a central role in the response to stress signals. From a yeast two-hybrid assay, we have identified Enigma Homolog 1 (ENH1) as a new binding partner of PKD1. Since in neurons, ENH1, associated with protein kinase Cepsilon, was shown to modulate the activity of N-type calcium channels, and the pore-forming subunit of the cardiac L-type voltage-gated calcium channel, alpha1C, possesses a potential phosphorylation site for PKD1, we studied here a possible role of ENH1 and PKD1 in the regulation of the cardiac L-type voltage-gated calcium channel.

Methods and results: PKD1-interacting proteins were searched by yeast two-hybrid screening. In vivo protein interactions in cardiomyocytes isolated from heart ventricles of newborn rats were tested by co-immunoprecipitation. Small interfering RNA and a dominant negative mutant of PKD1 were delivered into cardiomyocytes by use of an adenovirus. Calcium currents were measured by the patch-clamp technique. Both ENH1 and PKD1 interact with alpha1C in cardiomyocytes. This interaction is increased upon stimulation. Silencing of ENH1 prevented the binding of PKD1 to alpha1C. Moreover, a dominant negative mutant of PKD1 or the silencing of ENH1 inhibited the alpha-adrenergic-induced increase of L-type calcium currents.

Conclusion: We found a new binding partner, ENH1, and a new target, alpha1C, for PKD1 in neonatal rat cardiomyocytes. We propose a model where ENH1 scaffolds PKD1 to alpha1C in order to form a signalling complex that regulates the activity of cardiac L-type voltage-gated Ca(2+) channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / metabolism*
  • Adenoviridae / genetics
  • Adrenergic alpha-Agonists / pharmacology
  • Animals
  • Animals, Newborn
  • Calcium Channels, L-Type / genetics
  • Calcium Channels, L-Type / metabolism*
  • Calcium Signaling* / drug effects
  • Cells, Cultured
  • Genetic Vectors
  • HeLa Cells
  • Humans
  • Immunoprecipitation
  • LIM Domain Proteins
  • Membrane Potentials
  • Mutation
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / enzymology*
  • Patch-Clamp Techniques
  • Phenylephrine / pharmacology
  • Protein Binding
  • Protein Kinase C
  • Protein Kinases / genetics
  • Protein Kinases / metabolism*
  • Protein Structure, Tertiary
  • RNA Interference
  • RNA, Small Interfering / metabolism
  • Rabbits
  • Rats
  • Two-Hybrid System Techniques

Substances

  • Adaptor Proteins, Signal Transducing
  • Adrenergic alpha-Agonists
  • Cacna1c protein, rat
  • Calcium Channels, L-Type
  • LIM Domain Proteins
  • Pdlim5 protein, rat
  • Pdlim7 protein, rat
  • RNA, Small Interfering
  • Phenylephrine
  • Protein Kinases
  • protein kinase D
  • Protein Kinase C